Headline

The latest stories from AHA Today.

In addition to the seven new 2022 ICD-10 procedure codes announced in November, the Centers for Medicare & Medicaid Services on April 1 will implement two new ICD-10 procedure codes for reporting COVID-19 therapeutics
The AHA released a new issue of the COVID-19 Snapshot underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
President Biden announced he will deploy over 120 military medical personnel to hospitals in six states hit hard by the new COVID-19 variant: Michigan, New Mexico, New York, New Jersey, Ohio and Rhode Island.
Reps. Tom Cole, R-Okla., Markwayne Mullin, R-Okla., and Dina Titus, D-Nev., and Sens. Jim Inhofe, R-Okla., and Jacky Rosen, D-Nev., today introduced the Medical Student Education Authorization Act, AHA-supported legislation that would provide grants to public institutions of higher education to…
AHA is among the investors and partners taking part in a first-of-its-kind movement to promote equity in access to capital for investments in Black-founded and -led companies at the forefront of health care innovation. 
The American Organization for Nursing Leadership announced its 2022 Class of Fellows.
A new Commonwealth Fund report released is shedding light on how insurance costs of working Americans in every state are consuming a greater share of incomes than they did a decade ago.
The Centers for Medicare & Medicaid Services yesterday proposed that Medicare cover monoclonal antibodies that target amyloid to treat Alzheimer’s disease for beneficiaries enrolled in qualifying clinical trials.
The Cybersecurity and Infrastructure Security Agency, FBI and National Security Agency released recommendations to help health care and other critical infrastructure organizations prevent, detect and respond to common Russian state-sponsored cyber threats. 
The Food and Drug Administration has revised its provider and recipient fact sheets for the Johnson & Johnson COVID-19 vaccine due to reports of immune thrombocytopenia (ITP), a disorder that can cause easy or excessive bruising and bleeding due to very low platelet levels.